AbCellera Biologics Inc. (ABCL): Price and Financial Metrics
ABCL Price/Volume Stats
| Current price | $2.09 | 52-week high | $4.75 |
| Prev. close | $2.23 | 52-week low | $2.06 |
| Day low | $2.06 | Volume | 4,288,500 |
| Day high | $2.23 | Avg. volume | 4,104,015 |
| 50-day MA | $2.82 | Dividend yield | N/A |
| 200-day MA | $2.81 | Market Cap | 622.79M |
ABCL Stock Price Chart Interactive Chart >
AbCellera Biologics Inc. (ABCL) Company Bio
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics. It was founded in 2012 and headquartered in Vancouver, British Columbia.
ABCL Price Returns
| 1-mo | -19.15% |
| 3-mo | N/A |
| 6-mo | -15.73% |
| 1-year | -52.93% |
| 3-year | -79.37% |
| 5-year | N/A |
| YTD | -28.67% |
| 2024 | -48.69% |
| 2023 | -43.63% |
| 2022 | -29.16% |
| 2021 | -64.46% |
| 2020 | N/A |
Loading social stream, please wait...